Simpson Thacher recently represented Catalent Pharma Solutions, Inc. in connection with an amendment of Catalent’s senior secured credit facility in order to refinance approximately $1.45 billion aggregate principal amount of certain tranches of term loans. As part of the refinancing, lenders agreed to reduce the pricing and extend the maturity of certain term loans.
Catalent Pharma Solutions is the global leader in development solutions and advanced drug delivery technologies, providing world-wide clinical and commercial supply capabilities for drugs, biologics and consumer health products.
The Simpson Thacher team includes: Alden Millard, Brian Gluck and Mike Vernace (Banking and Credit).
